Antibody engineering toward high-sensitivity high-throughput immunosensing of small molecules

Norihiro Kobayashi1, Hiroyuki Oyama

  • 1Kobe Pharmaceutical University, Motoyama-Kitamachi, Higashinada-ku, Japan. no-kobay@kobepharma-u.ac.jp

The Analyst
|December 15, 2010
PubMed
Summary

Engineered antibodies overcome limitations in detecting small molecules (haptens). This antibody engineering enables sensitive, high-throughput hapten sensing for clinical and environmental analyses.